GleamWall
中文EN

Royalty Pharma Sub-Manager, LLC

New York NY · SEC CIK 0002081668

2026Q22026Q1 9 earlier quarters 🔒
$241.92M2026Q2 reported value
4Positions
100.0%Top 10 weight · largest 34.5%
0 / 1New / sold out
Reported value over time$241.92M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

CYTK 34.5%
ZBIO 25.1%
KLRA 22.4%
BHVN 18.1%

2026Q2 top buys estimated at quarter-end value

No buys this quarter

2026Q2 top sells estimated at quarter-end value

BCRX Sold out-$36.62M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
CYTK CYTOKINETICS, INC $83.52M34.52%980,392 00.0% — Unchanged
ZBIO ZENAS BIOPHARMA, INC. $60.61M25.05%2,388,150 00.0% — Unchanged
KLRA KAILERA THERAPEUTICS $54.09M22.36%2,455,357 2,455,357— — First reported
BHVN BIOHAVEN LTD $43.70M18.06%2,936,507 00.0% — Unchanged
BCRX BIOCRYST PHARMACEUTICALS INC $00.00%0 -3,846,154-100.0% -$36.62M Sold out